Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gross Anatomy of the Liver01:17

Gross Anatomy of the Liver

1.6K
The liver, the largest gland within the human body, is a firm and reddish-brown organ. This wedge-shaped structure weighs approximately 1.5 kg and occupies a significant portion of the right hypochondriac and epigastric regions. It extends more to the right of the body's midline than to the left.
Located under the diaphragm, the liver is almost entirely ensconced within the rib cage, providing it with substantial protection. Except for the superior most bare area, the liver's surface is...
1.6K
Liver Histology01:27

Liver Histology

3.4K
The microscopic anatomy of the liver is a complex and intricate system that comprises numerous structural units known as liver lobules, each of which is comparable in size to a sesame seed. These hexagonal structures consist of plates of liver cells or hepatocytes, which are characterized by their versatility and abundance of cellular apparatus like rough and smooth ER, Golgi apparatus, peroxisomes, and mitochondria.
Hepatocytes perform a variety of essential functions. They secrete...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Financial burden among liver transplant candidates is associated with financial distress and work impairment: A U.S. multicenter study.

Hepatology communications·2026
Same author

Uncommon Case of Hemophagocytic Lymphohistiocytosis as the First Presentation of Systemic Lupus Erythematosus.

ACG case reports journal·2026
Same author

Optimizing Liver Transplant Allocation for Hepatocellular Carcinoma: Development and Validation of a Survival Benefit-Based Model.

Clinical transplantation·2026
Same author

A Survey Study of Liver Donors' Information Needs on Recipient Outcomes in High-Risk Donation Scenarios.

Progress in transplantation (Aliso Viejo, Calif.)·2025
Same author

Predictors of response to terlipressin therapy in hepatorenal syndrome: Metabolomic and proteomic analysis from the CONFIRM trial.

Hepatology communications·2025
Same author

Recommendations to overcome barriers to transplant fellowship training: A report from the American Society of Transplantation Fellows Task Force.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2025
Same journal

Introduction to pediatric solid organ transplantation - not just little adults!

Current opinion in organ transplantation·2026
Same journal

Editorial introduction.

Current opinion in organ transplantation·2026
Same journal

Precision medicine guided development of new immunosuppression strategies in solid organ transplantation.

Current opinion in organ transplantation·2026
Same journal

Intestinal transplantation for tumors.

Current opinion in organ transplantation·2026
Same journal

Current state of medical rehabilitation for adult short bowel syndrome patients with intestinal failure.

Current opinion in organ transplantation·2026
Same journal

Update on costimulatory blockade in transplantation: a review of recent literature.

Current opinion in organ transplantation·2026
See all related articles

Related Experiment Video

Updated: Nov 27, 2025

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

2.7K

Profiling the liver graft.

Stela Celaj1, Josh Levitsky2

  • 1Department of Internal Medicine.

Current Opinion in Organ Transplantation
|December 5, 2020
PubMed
Summary
This summary is machine-generated.

Achieving operational tolerance in liver transplantation is key. Researchers are developing reliable biomarkers to guide immunosuppression withdrawal and improve allograft survival.

More Related Videos

Using a Chemical Biopsy for Graft Quality Assessment
05:00

Using a Chemical Biopsy for Graft Quality Assessment

Published on: June 17, 2020

5.4K
Author Spotlight: Enhancing Transplantation Research Through MicroCT Angiography in Murine Models
09:23

Author Spotlight: Enhancing Transplantation Research Through MicroCT Angiography in Murine Models

Published on: September 22, 2023

3.4K

Related Experiment Videos

Last Updated: Nov 27, 2025

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

2.7K
Using a Chemical Biopsy for Graft Quality Assessment
05:00

Using a Chemical Biopsy for Graft Quality Assessment

Published on: June 17, 2020

5.4K
Author Spotlight: Enhancing Transplantation Research Through MicroCT Angiography in Murine Models
09:23

Author Spotlight: Enhancing Transplantation Research Through MicroCT Angiography in Murine Models

Published on: September 22, 2023

3.4K

Area of Science:

  • Transplantation immunology
  • Genomics and transcriptomics

Background:

  • Operational tolerance is a critical goal in liver transplantation.
  • Validated biomarkers for tolerance and rejection are lacking in clinical practice.

Purpose of the Study:

  • To review current developments in liver allograft profiling.
  • To summarize findings from seminal studies on biomarkers.
  • To highlight progress in identifying biomarkers for immunosuppression withdrawal.

Main Methods:

  • Review of prior seminal studies.
  • Analysis of recent transcriptomic signature investigations.
  • Ongoing clinical trials for biomarker validation.

Main Results:

  • Progress in discovering reliable biomarkers for immunosuppression withdrawal.
  • Investigation of transcriptomic signatures for rejection and injury.
  • Development of new genomic and sequencing technologies.

Conclusions:

  • Clinical trials are validating biomarkers for tolerance.
  • Understanding rejection mechanisms is improving allograft survival.
  • Implementation of immunosuppression withdrawal protocols is anticipated.